Nanopore IsoRNC-Seq
Gene expression does not end with transcription — only a subset of transcribed mRNA isoforms is actively translated into protein at any given time. Standard RNA-seq cannot distinguish translating from non-translating transcripts, and short-read methods fragment the connectivity that defines isoform structure. CD Genomics offers Nanopore IsoRNC-Seq (Full-Length Translatome Sequencing) — a ribosome nascent chain (RNC) enrichment-based approach combined with Oxford Nanopore Technologies (ONT) long-read sequencing that captures only ribosome-bound, actively translating mRNA and sequences each molecule from end to end, delivering full-length translatome architecture at single-isoform resolution.
Unlike Ribo-seq, which generates short ~28-nucleotide ribosome-protected fragments that cannot resolve isoform structure, our IsoRNC-Seq workflow employs sucrose cushion ultracentrifugation to purify ribosome-nascent chain complexes (RNCs), followed by rRNA depletion and Nanopore cDNA sequencing. This approach preserves the complete sequence of every translating transcript — including exon connectivity, alternative splicing patterns, 5′-UTR and 3′-UTR boundaries — providing a direct experimental bridge between transcript diversity and functional protein output without computational transcript assembly.
Why Choose Nanopore IsoRNC-Seq for Translatome Analysis?
- Full-length translating transcript resolution — Sequences complete RNC-bound mRNA molecules from 5′ end to poly(A) tail, capturing every exon junction and isoform structure without fragmentation or assembly
- Translation-specific enrichment — Sucrose cushion ultracentrifugation isolates only ribosome-bound mRNA, excluding non-translating transcripts and avoiding false positives from non-coding RNAs
- Isoform-resolved translatome profiling — Long reads distinguish between translationally active and silent isoforms of the same gene, revealing condition-dependent isoform switching
- Integrated bioinformatics — Dedicated analysis pipeline for isoform identification, quantification, alternative splicing detection, and coding potential assessment
Introduction: The Translatome — Connecting Transcript Diversity to Protein Function
Alternative splicing generates extensive transcript diversity: over 95% of human multi-exon genes produce multiple mRNA isoforms, yet the vast majority have never been validated at the protein level. The central question in functional genomics is not simply which transcripts exist, but which ones are actually translated. The translatome — the subset of the transcriptome that is engaged with ribosomes and undergoing active translation — represents the functional interface between gene expression and proteome output.
Conventional approaches to study the translatome each have significant limitations. Ribo-seq (ribosome profiling) generates ~28-nucleotide ribosome-protected footprints, providing translation efficiency estimates but destroying all information about isoform structure, exon connectivity, and UTR architecture. Standard RNA-seq captures total RNA regardless of translational status, making it impossible to distinguish actively translated isoforms from non-translating RNA species. Short-read RNC-seq, while capturing translating mRNA, still relies on computational assembly to reconstruct full-length isoform sequences from fragmented reads — a process that frequently misassigns exon junctions and fails to identify complex or low-abundance isoforms.
Nanopore IsoRNC-Seq addresses all three limitations simultaneously: it selectively enriches for ribosome-bound translating mRNA, sequences each molecule in its full-length native form, and eliminates the need for computational transcript reconstruction. The result is a direct, unbiased view of the actively translating transcriptome at true isoform resolution.
What is Nanopore IsoRNC-Seq (Full-Length Translatome Sequencing)?
Nanopore IsoRNC-Seq is a translatome analysis method that combines ribosome nascent chain (RNC) enrichment with Oxford Nanopore long-read sequencing to capture and sequence full-length, actively translating mRNA molecules. The workflow begins with sucrose cushion ultracentrifugation, a gold-standard biochemical method that separates ribosome-bound mRNA from free RNA and non-translating ribosome subunits based on differential sedimentation through a dense sucrose layer. The purified RNC-mRNA is then subjected to rRNA depletion, reverse transcription, and Nanopore library preparation for long-read sequencing.
This approach provides three distinct layers of information from a single experiment: (1) full-length isoform sequences of all actively translated transcripts, including complete exon structures and splice junction connectivity; (2) quantitative expression profiles at the isoform level across experimental conditions; and (3) detection of translationally active isoforms, including those arising from alternative splicing, alternative promoter usage, and alternative polyadenylation. Because the starting material is biochemically enriched for ribosome-bound mRNA, the data inherently report on translational activity rather than total RNA abundance — a critical distinction for studies of translational regulation, isoform-specific translation, and condition-dependent translatome remodeling.
Key Advantages of Nanopore IsoRNC-Seq
Scientific Advantages
- Direct translatome readout at full-length resolution
RNC enrichment via sucrose cushion ultracentrifugation captures only mRNA that is physically bound to ribosomes and undergoing active translation. This biochemical specificity eliminates the background from non-translating RNA species that complicates standard RNA-seq analysis. Combined with Nanopore long reads, each sequencing read represents a complete, actively translated transcript — enabling direct identification of translationally active isoforms without computational inference.
- Isoform-level translatome discovery beyond short-read limitations
Short-read translatome methods (Ribo-seq, short-read RNC-seq) fragment the mRNA, losing the connectivity between exons within a single transcript. Published data demonstrate that Nanopore full-length RNC-seq identifies up to 4,429 annotated isoforms that are completely undetectable by short-read approaches, as well as 4,525 novel isoforms absent from public databases (Wu et al., Frontiers in Molecular Biosciences, 2022). Many of these long-read-only isoforms lack unique splice junctions that short reads could map to, yet are experimentally validated at the protein level by mass spectrometry.
Business & Project Advantages
- Comprehensive translatome data from a single experiment
Our IsoRNC-Seq generates isoform-resolved translatome sequences, splice junction maps, and quantitative expression profiles from one library preparation — eliminating the need to run separate Ribo-seq, RNA-seq, and isoform validation experiments. For researchers seeking broader transcriptome context, our Full-Length Transcriptome Profiling service provides complementary transcript-level analysis for comparative studies.
- Customized bioinformatics for translatome analysis
We provide end-to-end bioinformatics support aligned with translatome research needs. Standard deliverables include basecalled FASTQ files, genome-aligned BAM files with isoform annotations, transcript-level quantification matrices, alternative splicing event reports, and coding potential predictions. Advanced analysis — including condition-dependent isoform switching detection, differential isoform usage, and neoantigen prediction — is available through our Long-Read Sequencing Data Analysis pipeline.
Applications of Nanopore IsoRNC-Seq
Alternative Splicing and Isoform Function in Disease
- Full-length identification of translationally active splice isoforms in cancer, neurodegeneration, and genetic disorders
- Discovery of novel isoforms with altered domain structures, premature termination codons, or UTR rearrangements affecting translation efficiency
- Isoform-resolved translatome profiling of tumor vs. normal tissue to identify cancer-specific translating isoforms as therapeutic targets or biomarkers
Translational Regulation and Stress Response
- Profiling translatome remodeling under cellular stress (hypoxia, ER stress, nutrient deprivation, heat shock)
- Identification of uORF-containing isoforms subject to translational control
- Detection of isoform-specific translation efficiency changes across experimental conditions
Neoantigen and Immunotherapy Target Discovery
- Direct identification of tumor-specific translating isoforms for neoantigen prediction and personalized cancer vaccine development
- Detection of translationally active fusion transcripts and aberrant splice products in cancer
- Integration with our Splice Variation analysis and Transcriptomics with Long-Read Sequencing services for multi-dimensional splicing and translatome characterization
Non-Model Organism and Evolutionary Translatomics
- De novo translatome assembly for species without reference genomes
- Comparative translatome analysis across evolutionary distances
- Characterization of translation patterns in agriculturally or environmentally important organisms
Technology Overview — How IsoRNC-Seq Works
1. Cell Lysis and RNC Enrichment via Sucrose Cushion Ultracentrifugation
Cells or tissues are lysed under conditions that preserve ribosome-mRNA interactions. The lysate is layered onto a sucrose cushion (typically 30% sucrose) and ultracentrifuged to pellet ribosome-nascent chain complexes (RNCs) while free mRNA, tRNA, and unassembled ribosome subunits remain in the supernatant. This biochemical enrichment step is the defining feature of IsoRNC-Seq — it ensures that only actively translating mRNA enters the downstream workflow.
2. RNC-mRNA Isolation and rRNA Depletion
RNA is extracted from the purified RNC pellet. Ribosomal RNA (28S, 18S) is removed using probe-based depletion to maximize mRNA-mapping read yield. This step is critical because RNC-enriched RNA still contains residual rRNA from the pelleted ribosomes.
3. Reverse Transcription and cDNA Synthesis
The RNC-mRNA is reverse-transcribed into full-length cDNA using oligo-dT priming with template-switching technology to capture complete 5′ ends. The resulting cDNA preserves the full-length isoform structure of every translating transcript.
Figure 1. IsoRNC-Seq full-length translatome sequencing workflow: starting from cell lysis through RNC enrichment, rRNA depletion, reverse transcription, Nanopore library preparation, and long-read sequencing with isoform-level bioinformatics analysis.
4. Nanopore Library Preparation and Long-Read Sequencing
Full-length cDNA is prepared for ONT sequencing using the appropriate library kit. Adapters are ligated, and the library is loaded onto a Nanopore flow cell (PromethION or MinION). Long reads spanning entire transcript molecules are generated, with read lengths matching the full length of the original translating mRNA.
5. Basecalling, Isoform Identification, and Translatome Analysis
Raw ionic current data are basecalled using ONT Dorado. Full-length reads are aligned to the reference genome with minimap2. Isoform identification is performed using long-read transcript discovery tools (Pinfish, FLAIR2, StringTie2) to generate a comprehensive translatome annotation. Alternative splicing events are quantified, and isoform-level expression values are calculated. Coding potential analysis and ORF prediction identify the protein-coding capacity of each isoform.
Bioinformatics Analysis
| Analysis Feature | Basic | Advanced |
| Dorado basecalling and read QC | ✓ | ✓ |
| RNC-mRNA genome alignment (minimap2) | ✓ | ✓ |
| Full-length isoform identification and annotation | ✓ | ✓ |
| Transcript-level quantification (TPM) | ✓ | ✓ |
| Alternative splicing event detection (SE, A5SS, A3SS, MXE, IR, AFE, ALE) | ✓ | ✓ |
| Condition-dependent isoform switching analysis | — | ✓ |
| Coding potential and ORF prediction | — | ✓ |
| Neoantigen prediction from novel isoforms | — | ✓ |
| Integration with matched proteomics data | — | ✓ |
| Custom visualization and publication-ready figures | — | ✓ |
For detailed bioinformatics support options, see our Long-Read Sequencing Data Analysis Services.
Choosing the Right Translatome Analysis Approach
The table below compares IsoRNC-Seq with alternative translatome and transcriptome profiling methods to guide researchers in selecting the best approach for their experimental goals.
| Feature | IsoRNC-Seq (CDL2) | Ribo-seq | Standard RNA-seq |
| RNA captured | Ribosome-bound mRNA (translating) | Ribosome-protected fragments (~28 nt) | Total RNA (all transcripts) |
| Read length | Full-length transcripts | ~28 nt footprints | Fragment-dependent |
| Isoform resolution | ✔ Full-length isoform sequences | ✘ No isoform resolution | ✔ With computational assembly |
| Translation specificity | ✔ Direct RNC enrichment | ✔ Indirect (footprint) | ✘ No translational information |
| Novel isoform discovery | ✔ Direct detection | ✘ Not possible | ✔ Requires assembly |
| Throughput | Moderate–High | High | High |
| Best for | Full-length translatome profiling with isoform resolution | Translation efficiency and ribosome density | Comprehensive transcript detection |
Sample Requirements for IsoRNC-Seq
| Category | Requirement | Notes |
| Sample type | Cultured cells (adherent or suspension); fresh or flash-frozen tissue | RNC enrichment requires intact ribosome-mRNA complexes; RNase-free conditions essential |
| Minimum input | ≥1×107 cells (standard); ≥5×106 cells (high-yield optimized workflow) | Cell number depends on translation activity; higher input recommended for low-expression genes |
| Sample quality | High viability (>90%); fresh samples preferred | Degraded samples cannot preserve RNC complexes — flash-frozen pellets recommended |
| Species compatibility | All species with intact ribosomes | Standard rRNA depletion probes available for human, mouse, rat, and common model organisms |
| Recommended depth | 5–10 million reads per sample | Higher depth recommended for novel isoform discovery and low-abundance isoform detection |
| Growth condition documentation | Detailed culture conditions, treatment protocols, and harvest time points | Translatome profiles are highly condition-dependent; full metadata essential for meaningful analysis |
Please refer to our Sample Submission Guidelines for detailed instructions on cell and tissue sample preparation and shipping.
Why Choose CD Genomics for IsoRNC-Seq
Translatome expertise with long-read sequencing integration
CD Genomics has extensive experience in both translatome analysis and long-read sequencing. Our team understands the biochemical requirements for successful RNC enrichment — from sample preparation and sucrose cushion optimization through RNA extraction and library construction — and has optimized each step for consistent, reproducible results across diverse sample types and species.
End-to-end project support from experimental design to publication
We manage every stage of your IsoRNC-Seq project: initial feasibility assessment (including difficult samples or non-standard species), cell culture and RNC enrichment optimization, RNA extraction and QC, ONT sequencing on PromethION instruments, and a comprehensive bioinformatics pipeline that delivers translatome annotations, isoform quantifications, and alternative splicing reports ready for downstream analysis.
Integrated translatome and transcriptome analysis capabilities
Our platform spans the full RNA analysis spectrum — from total transcriptome (RNA-seq, Full-Length Transcriptome Profiling) to translatome (IsoRNC-Seq) to translation efficiency (Ribo-seq). This integrated capability allows researchers to combine multiple data types within a single project, providing a complete picture from transcription through translation.
Commitment to research-use-only quality standards
All IsoRNC-Seq services are performed under rigorous quality control protocols, with clear documentation of every experimental step from RNC enrichment yield through sequencing metrics to final bioinformatics deliverables.
Case Study: Efficient Detection of the Alternative Spliced Human Proteome Using Translatome Sequencing
Wu C, Lu X, Lu S, Wang H, Li D, Zhao J, Jin J, Sun Z, He QY, Chen Y, Zhang G. Efficient Detection of the Alternative Spliced Human Proteome Using Translatome Sequencing. Front Mol Biosci. 2022;9:895746. DOI: 10.3389/fmolb.2022.895746. (CC BY 4.0)
1. Background
Short-read Ribo-seq and RNC-seq provide translation-level information but cannot resolve full-length isoform structures, limiting their ability to connect transcript diversity to proteome complexity. The authors aimed to establish whether Nanopore long-read RNC-seq could identify translationally active isoforms that are invisible to short-read sequencing, and whether these isoforms could be validated at the protein level by mass spectrometry.
2. Methods
RNC-mRNA was enriched from MHCC97H hepatocellular carcinoma cells using sucrose cushion ultracentrifugation and sequenced on both Illumina (short-read RNC-seq) and Oxford Nanopore MinION (long-read RNC-seq) platforms. The long-read data were used to construct a comprehensive isoform-level translatome annotation. A three-frame translation of all identified isoforms generated a custom protein database for mass spectrometry-based proteomic identification.
3. Results
Figure 3. Single-molecule full-length RNC-seq improves isoform identification. (A) Categories of isoforms identified by Nanopore RNC-seq: annotated isoforms, annotated isoforms not found by short-read, and novel isoforms absent from RefSeq. (B) GAPDH isoform NM_002046 detected only by full-length Nanopore sequencing. (C) Novel PCBP2 isoform skipping exons 9–10 identified by long-read RNC-seq. (D) Mass spectrometry validation of the novel PCBP2 isoform via unique junction peptide. From Wu C, Lu X, Lu S, et al. Front Mol Biosci. 2022. (CC BY 4.0)
Key Findings
- 15,131 unique AS isoforms identified by Nanopore full-length RNC-seq in MHCC97H cells
- 4,525 novel isoforms absent from public databases — enabled by long-read translatome sequencing
- 4,429 annotated isoforms detectable only by long reads — invisible to short-read approaches
- 50 novel protein isoforms experimentally validated by mass spectrometry at FDR < 0.01
- Demonstrates that full-length translatome sequencing bridges the gap between transcript diversity and proteome complexity
4. Conclusions
This study demonstrated that Nanopore full-length RNC-seq (IsoRNC-Seq) provides isoform-resolution translatome data unattainable by short-read methods alone. The capability to directly sequence full-length translating transcripts identifies hundreds of actively translated isoforms that are completely missed by conventional approaches, and the translatome-guided protein database strategy provides a scalable framework for connecting transcript diversity to functional protein output.
FAQs
Q: What is the difference between IsoRNC-Seq and Ribo-seq?
Ribo-seq sequences short ~28-nucleotide ribosome-protected fragments, providing information about ribosome density and translation efficiency but losing all isoform structure. IsoRNC-Seq uses RNC enrichment to capture full-length ribosome-bound mRNA molecules, sequencing each transcript from end to end. This enables complete isoform identification, splice junction resolution, and discovery of novel isoforms that cannot be detected by Ribo-seq.
Q: How does IsoRNC-Seq differ from standard RNA-seq?
Standard RNA-seq captures all RNA in a sample regardless of translational status. IsoRNC-Seq biochemically enriches for mRNA that is physically bound to ribosomes and undergoing active translation, ensuring that the sequencing data specifically reports on the functional translatome rather than the total transcriptome.
Q: What types of alternative splicing events can be detected?
Our standard analysis detects all major alternative splicing event types: skipped exons (SE), alternative 5′ splice sites (A5SS), alternative 3′ splice sites (A3SS), mutually exclusive exons (MXE), retained introns (IR), alternative first exons (AFE), and alternative last exons (ALE). The long-read data also enables detection of complex multi-event isoforms that short reads cannot resolve.
Q: What is the minimum cell number required?
The standard protocol requires at least 1×107 cells for robust RNC enrichment. A high-yield optimized workflow is available for samples with 5×106 cells. For limiting samples or clinical specimens, we recommend consulting our project scientists for a feasibility assessment.
Q: What bioinformatics deliverables are provided?
Standard deliverables include basecalled FASTQ files, genome-aligned BAM files with isoform annotations, transcript-level quantification tables (counts and TPM), alternative splicing event reports, and a comprehensive project report. Advanced analysis adds condition-dependent isoform switching analysis, coding potential prediction, neoantigen prediction, and custom visualization.
Demo Data and Deliverable Examples
Deliverable 1 — Full-length isoform annotation and visualization
Genome browser tracks showing full-length isoform structures identified from IsoRNC-Seq data, including exon-intron structures, alternative splicing patterns, and isoform-level read coverage. Each read represents a complete translating transcript from 5′ end to poly(A) tail.
Deliverable 2 — Isoform-level quantification matrix
Count and TPM quantification matrix across all samples, with isoform annotations including gene symbol, transcript ID, exon composition, splicing event types, and coding potential status.
Deliverable 3 — Alternative splicing event report
Comprehensive report of all detected alternative splicing events across conditions, categorized by event type (SE, A5SS, A3SS, MXE, IR, AFE, ALE), with percent spliced-in (PSI) values and statistical comparisons.
Deliverable 4 — Novel isoform discovery and coding potential analysis
Annotated list of novel isoforms with full-length sequences, ORF predictions, coding potential scores, and comparison to reference annotations. Includes prioritization for downstream validation experiments.
References
- Wu C, Lu X, Lu S, Wang H, Li D, Zhao J, Jin J, Sun Z, He QY, Chen Y, Zhang G. Efficient Detection of the Alternative Spliced Human Proteome Using Translatome Sequencing. Front Mol Biosci. 2022;9:895746. DOI: 10.3389/fmolb.2022.895746. (CC BY 4.0)
- Román Á-C, Benítez DA, Díaz-Pizarro A, et al. Next generation sequencing technologies to address aberrant mRNA translation in cancer. NAR Cancer. 2024;6(2):zcae024. DOI: 10.1093/narcan/zcae024. (CC BY 4.0)
- Kozlova A, Sarygina E, Ilgisonis E, Tarbeeva S, Ponomarenko E. The Translatome Map: RNC-Seq vs. Ribo-Seq for Profiling of HBE, A549, and MCF-7 Cell Lines. Int J Mol Sci. 2024;25(20):10970. DOI: 10.3390/ijms252010970. (CC BY 4.0)